This report explores current clinical practice approaches for managing patients with HER2-positive advanced breast cancer and the challenges faced by healthcare providers responsible for making treatment decisions for these patients. Highlights include disparities in using a multidisciplinary approach to decision-making and treatment planning and knowledge of emerging strategies for patients with CNS metastases or for those with disease progression following multiple anti-HER2 therapies.
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.